PTK2 and glioma: Our previous research shows that the expression of SDC1 in human glioma is associated with advanced tumor progression and poor prognosis, and SDC1 knockdown inhibits glioma cell proliferation and invasion by deregulation of c-src/FAK related signal pathway (Shi et al., 2017).